|
Volumn 204, Issue 2, 2002, Pages 156-157
|
Response of severe psoriasis to infliximab [4]
|
Author keywords
Infliximab; Psoriasis; Psoriatic arthritis; TNF
|
Indexed keywords
CYCLOSPORIN;
ETANERCEPT;
FUMARIC ACID;
GLUCOCORTICOID;
HLA B27 ANTIGEN;
INDOMETACIN;
INFLIXIMAB;
METHOTREXATE;
NONSTEROID ANTIINFLAMMATORY AGENT;
RETINOID;
RHEUMATOID FACTOR;
ROFECOXIB;
TUMOR NECROSIS FACTOR ALPHA;
TUMOR NECROSIS FACTOR ALPHA ANTIBODY;
ADULT;
ARTHRALGIA;
BLOOD EXAMINATION;
BONE SCINTISCANNING;
CASE REPORT;
CLINICAL FEATURE;
CLINICAL TRIAL;
DISEASE ACTIVITY;
DISEASE SEVERITY;
DRUG EFFECT;
ERYTHRODERMA;
HAND;
HISTOLOGY;
HOSPITALIZATION;
HUMAN;
INFLAMMATION;
LETTER;
MALE;
PHOTOCHEMOTHERAPY;
PHOTOTHERAPY;
PRIORITY JOURNAL;
PSORIASIS;
PSORIASIS VULGARIS;
PSORIATIC ARTHRITIS;
REMISSION;
TREATMENT OUTCOME;
X RAY;
ADULT;
ANTIBODIES, MONOCLONAL;
ARTHRITIS, PSORIATIC;
DERMATOLOGIC AGENTS;
HUMANS;
INJECTIONS, INTRAVENOUS;
MALE;
PSORIASIS;
SEVERITY OF ILLNESS INDEX;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 0036214956
PISSN: 10188665
EISSN: None
Source Type: Journal
DOI: 10.1159/000051840 Document Type: Letter |
Times cited : (12)
|
References (9)
|